Masteroxyl 200 mg is an oil-based drostanolone enanthate injectable manufactured by Kalpa Pharmaceuticals and dosed at 200 mg/mL in a 10 mL vial.
Masteroxyl 200 mg is an injectable anabolic-androgenic steroid containing drostanolone enanthate, a longer-acting ester of the drostanolone hormone. Drostanolone is a derivative of dihydrotestosterone (DHT), meaning it is not aromatized to estrogen and does not undergo 5-alpha-reductase conversion.
The enanthate ester is a longer fatty acid chain than the propionate ester used in shorter-acting drostanolone preparations. This produces a slower release of drostanolone from the injection site and a correspondingly longer duration of activity, requiring less frequent administration. Drostanolone enanthate is not currently marketed as an FDA-approved human pharmaceutical product in the United States.
In non-medical bodybuilding settings, drostanolone enanthate is commonly referenced during cutting phases for its hardening and cosmetic effects. When used at supraphysiologic levels for physique or performance enhancement, the potential for adverse effects also increases and such use falls outside approved medical indications.
Masteroxyl 200 mg uses MCT oil as its carrier oil, providing the oil base for the drostanolone enanthate formulation.
Drostanolone enanthate is a longer-acting ester of drostanolone, a DHT-derived anabolic steroid designed for non-aromatizing properties. Its extended release profile distinguishes it from the propionate ester.
The enanthate ester releases drostanolone from the injection site more gradually than the propionate ester. This produces a longer duration of activity and a half-life of approximately 5–7 days, which means drostanolone enanthate requires less frequent injection than the propionate variant.
Like drostanolone propionate, drostanolone enanthate is a derivative of dihydrotestosterone, which cannot be aromatized to estrogen. This structural characteristic is why drostanolone enanthate does not cause water retention or gynecomastia through the aromatization pathway.
These characteristics explain why drostanolone enanthate is commonly referenced in non-medical cutting phases where a hardening, non-aromatizing compound with less frequent injection is preferred.
Drostanolone enanthate releases drostanolone more gradually than the propionate ester, with a half-life of approximately 5–7 days. This extended profile is why it is typically referenced as being administered once or twice weekly rather than every other day.
Kalpa Pharmaceuticals offers several injectable anabolic formulations built around different compounds and esters. The main practical distinctions between these preparations involve the compound's aromatization rate, ester composition, and injection frequency.
For a shorter-acting drostanolone preparation, Masteroxyl 100 uses the propionate ester. For multi-compound cutting blends, Cutaxyl 150 mg combines drostanolone propionate with testosterone propionate and trenbolone acetate. For a longer-acting testosterone base to stack alongside drostanolone enanthate, Testoxyl Enanthate 250 or Testoxyl Cypionate 250 are commonly referenced options.
The information below is provided for educational reference only. Drostanolone enanthate is a prescription-class androgen in jurisdictions where it remains available; medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring. Non-medical use falls outside approved indications.
In non-medical bodybuilding settings, drostanolone enanthate is commonly referenced in the range of 200–400 mg per week, typically administered as one or two injections per week, though such use falls outside approved medical indications. Because the enanthate ester has a longer half-life than the propionate ester, injection frequency is lower than with drostanolone propionate.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Non-medical cutting phase | 200–400 mg / week | Once or twice weekly |
| Longer cycle base compound | Typically combined with a testosterone base | Per cycle protocol |
| Pre-contest conditioning | Typically lower end of range | Once or twice weekly |
In non-medical bodybuilding contexts, drostanolone enanthate is frequently referenced as a secondary compound stacked alongside a testosterone base during cutting phases. Because drostanolone does not aromatize, a testosterone base is often included to maintain physiological testosterone levels and provide a base level of estrogen. Kalpa offers several testosterone preparations that are commonly referenced in this context, including Testoxyl Enanthate 250 and Testoxyl Cypionate 250.
Because of its longer half-life, drostanolone enanthate is sometimes preferred over the propionate ester for longer cycles where fewer injections are desirable. Cycle structure, duration and support compounds should be considered in the context of individual experience, health status and bloodwork where possible.
Because drostanolone enanthate does not aromatize, estrogenic side effects such as gynecomastia and water retention are not a concern through the aromatization pathway. However, drostanolone can contribute to androgenic side effects in predisposed individuals, including hair loss and acne.
Drostanolone enanthate is not liver toxic in the way oral C17-alpha-alkylated steroids are, but cholesterol and hematocrit levels should be monitored during use. Aromatase inhibitors such as Arimixyl are typically less relevant with drostanolone alone, but may be referenced when stacking with aromatizable compounds.
After completing a cycle with Masteroxyl 200 mg, post-cycle therapy is commonly recommended to help restore endogenous testosterone production and support hormonal recovery. Agents such as Clomixyl or Nolvaxyl are commonly referenced for this purpose.
Because drostanolone enanthate has a longer half-life than the propionate ester, some users reference a longer waiting period between the last injection and the start of PCT. PCT protocols vary based on cycle length, compounds used and individual factors.
Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Drostanolone enanthate is an androgen that can affect hormonal, reproductive, cardiovascular and hematologic function. Medical use requires appropriate diagnosis, clinical supervision and ongoing monitoring.
Drostanolone enanthate is not currently marketed as an FDA-approved human pharmaceutical product in the United States. Its safety and efficacy have not been established through the clinical trial process required for current FDA human pharmaceutical approval.
Use of drostanolone enanthate at supraphysiologic levels for bodybuilding or performance enhancement falls outside any approved indication and can increase exposure to androgen-related adverse effects.
Higher-than-physiologic drostanolone exposure can carry additional health risks. Product concentration and laboratory verification do not establish that non-medical use is safe or appropriate for an individual.
Drostanolone can suppress endogenous testosterone production through negative feedback on the hypothalamic-pituitary-gonadal axis. This can lead to reduced testicular function and impaired fertility.
Because drostanolone is a DHT derivative, it may contribute to androgenic side effects in predisposed individuals, including hair loss (androgenetic alopecia) and acne. Cardiovascular markers including lipid profile and blood pressure should be monitored during use.
Drostanolone does not aromatize to estrogen, so estrogenic side effects such as gynecomastia and water retention are not typically associated with its use through the aromatization pathway. Individual response and risk vary according to health status, exposure and other factors.
Anabolic steroid use is not appropriate for everyone. Medical guidelines identify circumstances in which androgen therapy should be avoided or carefully evaluated, including known or suspected prostate or male breast cancer, elevated hematocrit, certain cardiovascular conditions, thrombophilia and near-term fertility plans.
Existing cardiovascular disease, abnormal blood counts and other medical conditions should be discussed with a qualified healthcare professional before any androgen use is considered.
Medically supervised androgen therapy typically involves follow-up assessment to evaluate treatment response, adverse effects and relevant laboratory markers. Monitoring may include testosterone concentrations, hematocrit, lipid profile, and prostate-related evaluation.
For non-medical use of Masteroxyl 200 mg, such monitoring is not typically performed, which increases the risk of unrecognized adverse effects.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Masteroxyl 200 mg is supplied through the official Kalpa Pharmaceuticals distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official Kalpa Pharmaceuticals distribution chain.
To verify your Masteroxyl 200 mg product, use the security code on the vial label and cross-check it on the Kalpa official site. Official Kalpa Pharmaceuticals presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Masteroxyl 200 mg, drostanolone enanthate, release characteristics, product strength and how it compares to other preparations.
Masteroxyl 200 mg contains drostanolone enanthate, a non-aromatizing anabolic steroid. In non-medical bodybuilding settings it is commonly referenced during cutting phases for its hardening and cosmetic effects, though such use falls outside approved medical indications.
Because of its longer half-life of approximately 5–7 days, drostanolone enanthate is typically referenced as being administered once or twice weekly. This less frequent injection schedule distinguishes it from drostanolone propionate, which requires every-other-day administration.
Drostanolone enanthate is a derivative of dihydrotestosterone. Once released, drostanolone binds to the androgen receptor and promotes anabolism in skeletal muscle. Because it is a DHT derivative, it is not aromatized to estrogen and does not cause water retention or gynecomastia through the aromatization pathway.
Drostanolone enanthate is a longer-acting ester than drostanolone propionate, so circulating drostanolone rises more gradually after administration. Its effects are correspondingly longer-lived between injections.
The time required to notice a change depends on what is being evaluated, the individual's starting hormone levels, treatment circumstances and other biological factors.
There is no single best compound for cutting. Drostanolone enanthate is commonly referenced during cutting phases because it does not aromatize and requires less frequent injection than the propionate ester, but it is often stacked with a testosterone base and other compounds.
Kalpa Pharmaceuticals offers several products that are commonly referenced in this context, including Cutaxyl 150 mg as a multi-compound cutting blend and Stanoxyl 10 as an oral cutting compound.
Both contain drostanolone, but with different esters. Masteroxyl 200 mg uses the enanthate ester, which is longer-acting and requires less frequent injection. Masteroxyl 100 uses the propionate ester, which is shorter-acting and requires more frequent injection.
Both use the enanthate ester, but the active hormones differ. Drostanolone is a DHT-derived compound that does not aromatize to estrogen. Testosterone does aromatize, meaning it converts to some degree of estrogen. Kalpa offers Testoxyl Enanthate 250 as a testosterone enanthate preparation for users seeking an aromatizable longer-acting testosterone.
A milligram amount cannot be classified as appropriate or excessive without considering the medical indication, individual response, laboratory results, treatment schedule and the specific product being used. In non-medical contexts, drostanolone enanthate is commonly referenced in the 200–400 mg per week range.
It is also important to distinguish a dose in milligrams from a product's concentration in mg/mL. Masteroxyl 200 mg is labeled at 200 mg/mL; that concentration does not by itself specify how much should be administered.
Masteroxyl 200 mg is labeled at 200 mg of drostanolone enanthate per mL. It is supplied in a 10 mL vial, giving 2,000 mg of total labeled drostanolone enanthate content per vial.
Drostanolone is a DHT-derived compound. DHT is associated with androgenetic alopecia in predisposed individuals. Because of this, drostanolone enanthate may contribute to hair loss in individuals who are already predisposed to DHT-related hair loss.
Individual response varies. Anyone concerned about androgen-related hair loss should discuss this with a qualified healthcare professional.
The concentration difference reflects the different esters. The enanthate ester has a longer fatty acid chain, which makes it easier to keep in stable solution at higher concentrations than the propionate ester. This is why drostanolone enanthate is typically formulated at 200 mg/mL and drostanolone propionate is typically formulated at 100 mg/mL.
MastE is fucking bad ass! After two weeks, believe it or not, I started getting a lot more comments about hardness and graininess. I gained weight on DBol, but started Mast after that. Gained about two pounds in six weeks at 60mg 3 x/week. I split it up cuz a 200mg shot of mast makes me RAGE! Very badly. I've found that I'm cool if I split it up. It also definitely made me stronger and Hornier. Gf is wondering wtf, especially because of my age. I freaking LOVE this Mast and highly recommend it. I'm totally pleased with not only products, but prices, shipping, communication, and the relationship I have with this awesome source.
Please log in to write Masteroxyl 200 mg review.
You can order steroids from here without prescription. We will offer you the best and 100% original steroids. You wont need to hesitate about the authenticity because we don't sell fake products. We don't have the right to scam and play with your health, nobody does. So feel free to get steroids from our steroid shop. We have injectable steroids, oral steroids, post cycle therapy drugs, diuretics, fat-burners and so on. We will try our best to satisfy you and support you. Don't forget that you can always contact us if you are having any problem.
May 17, 2019
The Mast E kicked in and brought out a lot of veins that I can only attribute to the addition of the Mast. I would say the products are dosed correctly.
Ill be using these guys for awhile and recommending them to friends and family!